OrbiMed’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $117M | Buy |
|
|||||
|
2024
Q3 | $119M | Buy |
|
|||||
|
2024
Q2 | $102M | Sell |
|
|||||
|
2024
Q1 | $90.3M | Hold |
|
|||||
|
2023
Q4 | $67.3M | Buy |
|
|||||
|
2023
Q3 | $64.1M | Sell |
|
|||||
|
2023
Q2 | $74.9M | Sell |
|
|||||
|
2023
Q1 | $119M | Sell |
|
|||||
|
2022
Q4 | $126M | Buy |
|
|||||
|
2022
Q3 | $102K | Buy |
|
|||||
|
2022
Q2 | $1.5K | Sell |
|
|||||
|
2022
Q1 | $3.05M | Sell |
|
|||||
|
2021
Q4 | $5.29M | Sell |
|
|||||
|
2021
Q3 | $5.98M | Hold |
|
|||||
|
2021
Q2 | $5.03M | Sell |
|
|||||
|
2021
Q1 | $14.9M | Sell |
|
|||||
|
2020
Q4 | $91.9M | Hold |
|
|||||
|
2020
Q3 | $75.7M | Sell |
|
|||||
|
2020
Q2 | $89.7M | Sell |
|
|||||
|
2020
Q1 | $88.3M | Buy |
|
|||||
|
2019
Q4 | $98.9M | Sell |
|
|||||
|
2019
Q3 | $63.1M | Buy |
|
|||||
|
2019
Q2 | $126M | Hold |
|
|||||
|
2019
Q1 | $98.7M | Buy |
|
|||||
|
2018
Q4 | $85.2M | Sell |
|
|||||
|
2018
Q3 | $138M | Buy |
|
|||||
|
2018
Q2 | $59.8M | Buy |
|
|||||
|
2018
Q1 | $23.8M | Buy |
|
|||||
|
2017
Q4 | $5.53M | Buy |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $31.2M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $16.1M | Buy |
|